A retrospective study to assess efficacy and safety of regorafenib as second-line chemotherapy after treatment with sorafenib in patients with Hepatocellular carcinoma
Latest Information Update: 18 Aug 2020
At a glance
- Drugs Regorafenib (Primary)
- Indications Liver cancer
- Focus Adverse reactions; Therapeutic Use
- 18 Aug 2020 New trial record
- 17 Jul 2020 Results published in the Medicine